A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Conditions
Nasopharyngeal Cancer Recurrent
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Contact: Principal Investigator (Santanu Samanta, MD)University of California, Irvine, Irvine, California, United States
Contact: Principal Investigator (Bao-An Huynh)University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Sue S Yom, MD)Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Dong Shin, MD)Boston Medical Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Peter C Everett, MD)University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Paul Swiecicki, MD)Henry Ford Cancer Center, Detroit, Michigan, United States
Contact: Principal Investigator (Matthew Wilkins, MD)Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Trisha M Wise-Draper, M.D., Ph.D.)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Tamara Sussman, MD)Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Contact: Principal Investigator (Danh Pham, MD)Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Stuart Wong, MD)Princess Margaret Cancer Centre, Toronto, Canada
Contact: Principal Investigator (Anna Spreafico, MD, PhD)
Study leads
Study Director
Coherus Oncology